 PONTE VEDRA, Fla., Jan. 07, 2022 GLOBE NEWSWIRE -- Treace Medical Concepts, Inc. Treace Nasdaq: TMCI, a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgical treatment of hallux valgus commonly known as bunions, today announced that John T. Treace, Chief Executive Officer, and Mark L. Hair, Chief Financial Officer, will present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022 at 4:30 p.m. Eastern Time. 